Interferon gamma-1b
- Generic Name
- Interferon gamma-1b
- Brand Names
- Actimmune
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 98059-61-1
- Unique Ingredient Identifier
- 21K6M2I7AG
- Background
Human Interferon gamma-1b (140 residues), produced from E. coli. Production of Actimmune is achieved by fermentation of a genetically engineered Escherichia coli bacterium containing the DNA which encodes for the human protein. Purification of the product is achieved by conventional column chromatography.
...
- Indication
Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis.
- Associated Conditions
- Chronic Granulomatous Disease (CGD), Severe, malignant Osteopetrosis
- Associated Therapies
- -
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Amgen reports Q3 2024 financial results: total revenues up 23% to $8.5 billion, GAAP EPS increased 62% to $5.22, non-GAAP EPS up 13% to $5.58, driven by strong product sales and pipeline investments.
Fennec Pharmaceuticals Strengthens Executive Leadership
Fennec Pharmaceuticals appoints Pierre S. Sayad as Chief Medical Officer, Terry Evans as Chief Commercial Officer, and Christiana Cioffi as Chief Strategy Officer to strengthen its executive team and accelerate the commercialization of PEDMARK, the first therapy to reduce ototoxicity risk from cisplatin treatment in pediatric patients.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath